Table 5.
Death | MI | CVD Mortality | |||||||
---|---|---|---|---|---|---|---|---|---|
MVEQ | 1.29* (1.20, 1.39) | 1.29* (1.20‒1.38) | 1.29* (1.20‒1.38) | 1.20 † (1.04, 1.39) | 1.20 † (1.04‒1.39) | 1.20 † (1.03‒1.39) | 1.31* (1.15‒1.50) | 1.30* (1.14‒1.49) | 1.30* (1.14‒1.49) |
Ln LF | 0.94* (0.92‒0.96) | 0.89* (0.86‒0.92) | 0.95 † (0.91‒0.99) | 0.92 † (0.85‒0.99) | 0.92* (0.88‒0.96) | 0.89* (0.84‒0.95) | |||
Ln HF | 1.07* (1.03‒1.11) | 1.05 (0.97‒1.13) | 1.04 (0.97‒1.12) |
The initial models used vital exhaustion as the exposure, with subsequent models adjusted for LF and HF heart rate variability. All models included adjustment for age, sex, BMI, race, hypertension, CHD, and diabetes mellitus. CVD indicates cardiovascular disease; HF, high frequency; LF, low frequency; MI, myocardial infarction; and MVEQ, Maastricht Vital Exhaustion Questionnaire.
P<0.001.
P<0.01.